Home/Peptides/GLP-1 S Semaglutide 5mg
GLP-1 S Semaglutide 5mg
Weight Loss
WEIGHT LOSS

GLP-1 S Semaglutide 5mg

Starter Dose — GLP-1 Receptor Agonist for Weight Loss

Semaglutide 5mg — ideal starter vial for GLP-1 weight loss protocols. Same compound as Ozempic/Wegovy at a research-grade price point for dose titration.

  • 15-20% body weight reduction in clinical trials at therapeutic doses
  • Ideal starter size for dose titration and GI adaptation
  • Same compound as Ozempic/Wegovy
  • Dramatically reduces appetite via hypothalamic GLP-1 receptors
  • Glucose-dependent insulin stimulation — low hypoglycemia risk
$79.99
at Apollo Peptide Sciences
COA Verified · US Domestic
Buy GLP-1 S Semaglutide 5mg

COA verified · US domestic shipping

Semaglutide 5mg: The Right Starting Size for Your GLP-1 Protocol

Starter Value

Perfect first vial — 20 weeks of starter dosing at 0.25mg/week while you assess tolerability.

Same as Ozempic

Identical active compound to Ozempic and Wegovy at a fraction of pharmaceutical pricing.

15-20% Weight Loss

At therapeutic doses, semaglutide produces 15-20% body weight reduction in 68-week trials.

GI Adaptation

Starting low allows the gut to adapt — minimizing nausea and improving tolerability at therapeutic doses.

The Science Behind GLP-1 S Semaglutide 5mg

Semaglutide 5mg is the preferred starting size for GLP-1 receptor agonist protocols. At 0.25mg/week starting dose, a 5mg vial provides roughly 20 weeks of initial dosing — ideal for those new to GLP-1 therapy assessing tolerability before committing to larger vials.

Clinical Results

Semaglutide (Ozempic/Wegovy active compound) has demonstrated 15-20% body weight reduction in 68-week clinical trials.

Complete GLP-1 S Semaglutide 5mg Benefits

  • 15-20% body weight reduction in clinical trials at therapeutic doses
  • Ideal starter size for dose titration and GI adaptation
  • Same compound as Ozempic/Wegovy
  • Dramatically reduces appetite via hypothalamic GLP-1 receptors
  • Glucose-dependent insulin stimulation — low hypoglycemia risk

GLP-1 S Semaglutide 5mg Dosing Protocol

Starter Protocol:

Reconstitute with 2mL bacteriostatic water (2.5mg/mL)

Week 1-4: 0.1mL (0.25mg) subcutaneous weekly

Week 5-8: 0.2mL (0.5mg) weekly

Move to 10mg vial to continue escalation

All information on this site is for educational purposes only. Always consult with a qualified healthcare provider before use. COA documentation is available from Apollo Peptide Sciences for all products.

Get GLP-1 S Semaglutide 5mg

Apollo Peptide Sciences — COA verified, US domestic, fast shipping.

Shop View Stack Protocols
Certificate of Analysis (COA)
US Domestic Shipping
COA-Verified Purity
24–48hr Processing
$79.99
at Apollo Peptide Sciences
Weight Loss

GLP receptor agonists work via hypothalamic appetite regulation and metabolic enhancement — proven in large-scale clinical trials.

All Weight Loss Peptides

Stack GLP-1 S Semaglutide 5mg With

BPC-157
Healing

BPC-157

The #1 Healing Peptide in the World

BPC-157 is the most studied healing peptide — accelerates tendon, ligament, muscle, and gut repair with zero systemic side effects and no known LD50.

healing gut tendons
NAD+ 500mg
Anti-Aging

NAD+ 500mg

Cellular Energy & Longevity Cofactor

NAD+ is the master cellular energy molecule that declines 50% by age 50 — supplementation restores sirtuin activity, DNA repair, and mitochondrial function.

NAD+ longevity mitochondria
GLP-1 S (Semaglutide)
Weight Loss

GLP-1 S (Semaglutide)

Next-Gen GLP-1 Receptor Agonist for Weight Loss

Semaglutide (GLP-1 S) is a GLP-1 receptor agonist with clinical trials showing 15-20% body weight reduction — the most effective pharmacological weight loss agent studied.

GLP-1 semaglutide weight loss